1. Home
  2. PULM vs MTEX Comparison

PULM vs MTEX Comparison

Compare PULM & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • MTEX
  • Stock Information
  • Founded
  • PULM 2003
  • MTEX 1993
  • Country
  • PULM United States
  • MTEX United States
  • Employees
  • PULM 22
  • MTEX N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • PULM Health Care
  • MTEX Health Care
  • Exchange
  • PULM Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • PULM 21.9M
  • MTEX 23.0M
  • IPO Year
  • PULM N/A
  • MTEX 1999
  • Fundamental
  • Price
  • PULM $5.80
  • MTEX $11.59
  • Analyst Decision
  • PULM
  • MTEX
  • Analyst Count
  • PULM 0
  • MTEX 0
  • Target Price
  • PULM N/A
  • MTEX N/A
  • AVG Volume (30 Days)
  • PULM 131.2K
  • MTEX 6.5K
  • Earning Date
  • PULM 11-08-2024
  • MTEX 11-12-2024
  • Dividend Yield
  • PULM N/A
  • MTEX N/A
  • EPS Growth
  • PULM N/A
  • MTEX N/A
  • EPS
  • PULM N/A
  • MTEX N/A
  • Revenue
  • PULM $10,005,000.00
  • MTEX $121,552,000.00
  • Revenue This Year
  • PULM N/A
  • MTEX N/A
  • Revenue Next Year
  • PULM $1.00
  • MTEX N/A
  • P/E Ratio
  • PULM N/A
  • MTEX N/A
  • Revenue Growth
  • PULM 47.05
  • MTEX N/A
  • 52 Week Low
  • PULM $1.55
  • MTEX $6.75
  • 52 Week High
  • PULM $8.44
  • MTEX $13.00
  • Technical
  • Relative Strength Index (RSI)
  • PULM 57.17
  • MTEX 58.91
  • Support Level
  • PULM $5.80
  • MTEX $11.13
  • Resistance Level
  • PULM $6.57
  • MTEX $12.10
  • Average True Range (ATR)
  • PULM 0.43
  • MTEX 0.83
  • MACD
  • PULM -0.14
  • MTEX 0.01
  • Stochastic Oscillator
  • PULM 36.69
  • MTEX 67.11

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: